Overview

• Healthcare technology firm's Q4 revenue grew 11%, beating analyst expectations

• Adjusted EPS for Q4 beat consensus, rising 12% yr/yr

• Company projects FY 2026 revenue growth of 6% to 8%

Outlook

• Merit Medical Systems expects fiscal year 2026 revenue of $1.610 bln to $1.630 bln

• Company forecasts fiscal year 2026 non-GAAP EPS of $4.01 to $4.15

Result Drivers

• OPERATING MARGIN IMPROVEMENT - GAAP operating margin improved to 13.8% from 10.3% in the prior year, driven by higher sales and cost management

Company press release: ID:nGNX253D6D

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Revenue	Beat	$393.90 mln	$389.87 mln (11 Analysts)
Q4 Adjusted EPS	Beat	$1.04	$0.95 (10 Analysts)
Q4 EPS		$0.63
Q4 Adjusted Net Income	Beat	$62.50 mln	$54.86 mln (10 Analysts)

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

• Wall Street's median 12-month price target for Merit Medical Systems Inc is $106.00, about 29.9% above its February 23 closing price of $81.61

• The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 22 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.